cromakalim has been researched along with nilvadipine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izawa, T; Izumi, H; Jinno, Y; Kaneta, S; Ogawa, N; Okada, Y; Tanaka, Y | 1 |
| Endo, M; Izawa, T; Izumi, H; Jinno, Y; Kawahara, J; Takeuchi, A | 1 |
| Harada, K; Kawahara, J; Kusaka, M; Okada, Y; Tokiwa, T; Uzumaki, H | 1 |
| Izawa, T; Kashiwabara, T; Kawahara, J; Ogawa, N; Okada, Y | 1 |
4 other study(ies) available for cromakalim and nilvadipine
| Article | Year |
|---|---|
Effects of KRN4884, a novel K channel opener, on the cardiovascular system in anesthetized dogs: a comparison with levcromakalim, nilvadipine, and nifedipine.
Topics: Anesthesia; Animals; Antihypertensive Agents; Aorta; Benzopyrans; Calcium Channel Blockers; Cromakalim; Dogs; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Male; Nifedipine; Potassium Channels; Pyridines; Pyrroles; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents | 1995 |
KRN4884, a novel K channel opener: antihypertensive effects in conscious renal hypertensive dogs.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Calcium Channel Blockers; Cromakalim; Dogs; Female; Hypertension, Renal; Male; Nifedipine; Potassium Channels; Pyridines; Pyrroles | 1997 |
Effects of KRN4884 (a novel K+ channel opener), levcromakalim, nilvadipine and propranolol on endothelin-1-induced heart disorders in anesthetized rats.
Topics: Anesthesia; Animals; Antihypertensive Agents; Blood Pressure; Bronchoconstrictor Agents; Cromakalim; Electrocardiography; Endothelin-1; Heart Diseases; Heart Rate; Injections, Intra-Arterial; Male; Methacholine Chloride; Nifedipine; Potassium Channels; Propranolol; Pyridines; Rats; Rats, Wistar | 1998 |
Antihypertensive properties of KRN4884, a novel long-lasting potassium channel opener.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Calcium Channel Blockers; Cromakalim; Dose-Response Relationship, Drug; Hypertension; In Vitro Techniques; Male; Nifedipine; Pyridines; Rats; Rats, Inbred SHR; Rats, Wistar; Time Factors; Vasodilation | 1999 |